Literature DB >> 11141330

Staphylococcal enterotoxin-B-induced lethal shock in mice is T-cell-dependent, but disease susceptibility is defined by the non-T-cell compartment.

M R Anderson1, M Tary-Lehmann.   

Abstract

Here we introduce a murine model for SEB-induced lethal shock that relies on the administration of SEB alone and does not involve hepatotoxicity by avoiding pretreatment with the hepatotoxin D-galactosamine. In the absence of D-gal, we first identified SEB-susceptible and -resistant H-2(k)-congenic mouse strains. In contrast with what is well established for the classic D-gal-dependent model and what therefore is anticipated for the human disease, the levels of TNF produced did not define susceptibility in our model. The SEB-induced TNF response in vitro and in vivo was stronger in resistant B10.BR mice than in susceptible C3H/HeJ mice. Neither the magnitude nor the quality of the T cell response induced by SEB defined susceptibility. Adoptive transfer experiments in C3H-SCID recipient mice demonstrated that induction of the disease is T-cell-dependent. T cells from resistant and susceptible mice both transferred disease susceptibility to H-2(k)-congenic C3H-SCID mice, indicating that disease susceptibility is downstream from T cell activation, at the level of the target organ itself, which responds differently to T-cell-induced inflammation. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11141330     DOI: 10.1006/clim.2000.4960

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  11 in total

1.  Application of a Chimeric Protein Construct having Enterotoxin B and Toxic Shock Syndrome Toxin Domains of S. aureus in Immunodiagnostics.

Authors:  R Shylaja; Devi Kalyan Kumar Thakasi; H S Murali; K Prakash Narayana Reddy; H V Batra
Journal:  Indian J Microbiol       Date:  2012-03-31       Impact factor: 2.461

2.  Differential regulation of cytokine production by CD1d-restricted NKT cells in response to superantigen staphylococcal enterotoxin B exposure.

Authors:  Melanie J Ragin; Nisebita Sahu; Avery August
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  Increased sensitivity to staphylococcal enterotoxin B following adenoviral infection.

Authors:  Timur O Yarovinsky; Michael P Mohning; Mary A Bradford; Martha M Monick; Gary W Hunninghake
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

4.  Mucosal tolerance to a bacterial superantigen indicates a novel pathway to prevent toxic shock.

Authors:  L Vincent Collins; Kristina Eriksson; Robert G Ulrich; Andrej Tarkowski
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

5.  A novel block to mouse mammary tumor virus infection of lymphocytes in B10.BR mice.

Authors:  Chioma M Okeoma; Ming Shen; Susan R Ross
Journal:  J Virol       Date:  2007-11-14       Impact factor: 5.103

6.  Syndecan-1 is an in vivo suppressor of Gram-positive toxic shock.

Authors:  Kazutaka Hayashida; Ye Chen; Allison H Bartlett; Pyong Woo Park
Journal:  J Biol Chem       Date:  2008-05-22       Impact factor: 5.157

Review 7.  Therapeutic down-modulators of staphylococcal superantigen-induced inflammation and toxic shock.

Authors:  Teresa Krakauer
Journal:  Toxins (Basel)       Date:  2010-07-29       Impact factor: 4.546

8.  A role for the Tec family kinase ITK in regulating SEB-induced interleukin-2 production in vivo via c-jun phosphorylation.

Authors:  Melanie J Ragin; Jianfang Hu; Andrew J Henderson; Avery August
Journal:  BMC Immunol       Date:  2005-07-22       Impact factor: 3.615

Review 9.  Staphylococcal Superantigens Spark Host-Mediated Danger Signals.

Authors:  Teresa Krakauer; Kisha Pradhan; Bradley G Stiles
Journal:  Front Immunol       Date:  2016-02-02       Impact factor: 7.561

Review 10.  PI3K/Akt/mTOR, a pathway less recognized for staphylococcal superantigen-induced toxicity.

Authors:  Teresa Krakauer
Journal:  Toxins (Basel)       Date:  2012-11-15       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.